Akynzeo 300-0.5 MG capsules
Ended Awarded Last action
- Contract number
- SPE2DR26F9LX3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,379
Award facts
- Contract value 100% obligated
- $57,379.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order from the Defense Logistics Agency (DLA) valued at $57,379.42 for AKYNZEO 300-0.5 mg capsules, a prescription medication used to prevent nausea and vomiting associated with chemotherapy. This competitively awarded, firm fixed-price delivery order was issued on January 20, 2026, with an ultimate completion date of January 21, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition.
This delivery order was issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The IDC structure allows the DLA to efficiently procure critical pharmaceutical commodities across multiple therapeutic domains on an as-needed basis, with Amerisourcebergen demonstrating substantial capability to fulfill federal medical supply requirements through its extensive pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26F9LX3?
SPE2DR26F9LX3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LX3 worth?
The government has obligated $57,379 on SPE2DR26F9LX3.
Is contract SPE2DR26F9LX3 an order under another contract?
Yes. SPE2DR26F9LX3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LX3 competed?
The extent of competition for SPE2DR26F9LX3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award